Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Danish National Chronic Myeloid Neoplasia Registry

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Central nervous system tumor registration in the Swedish Cancer Register and Inpatient Register between 1990 and 2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997-2013: a nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Danish in-hospital cardiac arrest registry (DANARREST)

    Research output: Contribution to journalReviewResearchpeer-review

  1. Association of the blood eosinophil count with end-organ symptoms

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hydrochloric acid prolongs the lifetime of central venous catheters in haematologic patients with bacteraemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Influence of improved metabolic control on cardiovascular risk in children with type 1 diabetes

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  4. Dansk Melanom database: Årsrapport 2017

    Research output: Book/ReportReportCommunication

View graph of relations

AIM: The Danish National Chronic Myeloid Neoplasia Registry (DCMR) is a population-based clinical quality database, introduced to evaluate diagnosis and treatment of patients with chronic myeloid malignancies. The aim is to monitor the clinical quality at the national, regional, and hospital departmental levels and serve as a platform for research.

STUDY POPULATION: The DCMR has nationwide coverage and contains information on patients diagnosed at hematology departments from January 2010 onward, including patients with essential thrombocythemia, polycythemia vera, myelofibrosis, unclassifiable myeloproliferative neoplasms, chronic myelomonocytic leukemia, and chronic myeloid leukemia.

MAIN VARIABLES: Data are collected using standardized registration forms (so far up to four forms per patient), which are consecutively filled out online at time of diagnosis, after 2-year and 5-year follow-ups, and at end of follow-up. The forms include variables that describe clinical/paraclinical assessments, treatment, disease progression, and survival - disease-specific variables - as well as variables that are identical for all chronic myeloid malignancies.

DESCRIPTIVE DATA: By the end of 2014, the DCMR contained data on 2,690 patients with an inclusion rate of ∼500 patients each year. Since the registry was established, annual reports have shown consistently high national coverage and data completeness, ≥90% and ≥88%, respectively.

CONCLUSION: The DCMR is a national database used for monitoring the quality of patient care in patients with chronic myeloid malignancies, but until validation has been conducted, the data must be used with caution. However, the DCMR is a valuable data source accessible to clinicians and researchers.

Original languageEnglish
JournalClinical Epidemiology
Volume8
Pages (from-to)567-572
Number of pages6
ISSN1179-1349
DOIs
Publication statusPublished - 2016

ID: 49464210